Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Amarantus Bioscience Holdi AMBS
Posted On: 02/07/2015 9:55:37 AM
Post# of 30066
Avatar
Posted By: the gipper
MJFF and Eltoprazine have a notable history together, namely funding .
https://www.michaeljfox.org/files/accelerate/...nics_1.pdf
Jamie Eberling of MJFF has high hopes for Eltoprizine " Levodopa, the gold standard PD drug, is designed to get dopamine neurons to make more dopamine, in order to treat symptoms caused by the loss of dopamine taking place in PD. But levodopa may also cause serotonin neurons to make dopamine, something they’re not designed to do, and this might cause dyskinesia. Researchers hope Eltoprazine could prevent this process from taking place.

According to MJFF’s Jamie Eberling, PhD, today’s announcement suggests Eltoprazine may do just this. "
The MJFF''s history with Eltoprazine is unmistakable and continued grant funding will not be any surprise. We should be hearing something of interest in regards to Eltoprizine soon.
Just go to MJFF for some interesting reading re. Eltoprazine.













(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site